Transplant International

Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors

Björn Nashan

Bile acids analysis: a tool to assess graft function in human liver transplantation

Hector Vilca Melendez, Mohamed Rela, Kenneth D. R. Setchell, Gerard M. Murphy, Nigel D. Heaton

Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejection

Michael Mengel, Imke Mueller, Matthias Behrend, Reinhard von Wasielewski, Joerg Radermacher, Anke Schwarz, Hermann Haller, Hans Kreipe

Intrathymic injection of anti-Fas monoclonal antibody prolongs murine non-vascularized cardiac allograft survival

Arjang Djamali, Kenneth R. Waller, Jonathan McAnulty, Debra Hullett, Bryan N. Becker, Jon S. Odorico

Is graft size a major risk factor in living-donor adult liver transplantation?

M. Shimada, H. Ijichi, Y. Yonemura, N. Harada, S. Shiotani, M. Ninomiya, T. Yoshizumi, Y. Soejima, T. Suehiro, Y. Maehara

Ischemic preconditioning fails to improve microcirculation but increases apoptotic cell death in experimental pancreas transplantation

Oliver Drognitz, Xuemei Liu, Robert Obermaier, Hannes Neeff, Ernst von Dobschuetz, Ulrich Theodor Hopt, Stefan Benz

Six-month cardiovascular changes in cyclosporine-treated recipients of corneal grafts: serial baroreflex responses

Malika Bouhaddi, Bernard Delbosc, Jacques-Olivier Fortrat, Marie-Thérèse Henriet, Sylvie Cappelle, Didier Ducloux, Jean-Marc Chalopin, Jacques Regnard

July 2004

ESOT - Novartis Study Grant: Call for Application, Guidelines and Application Form